Bone Biologics (BBLG) Interest Coverage Ratio Growth (3y) (2017 - 2024)
Powered by 
Analysis
Bone Biologics (BBLG) Interest Coverage Ratio Growth (3y) (2017 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 29.79% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 33.30% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -35.50% |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 81.16% |
| 10 | Bone Biologics | 1.00 Mn | 1.00 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 16.93% |
| Sep 30, 2024 | -58.44% |
| Dec 31, 2021 | -80.07% |
| Sep 30, 2021 | -35.43% |
| Jun 30, 2021 | 25.33% |
| Mar 31, 2021 | 38.25% |
| Dec 31, 2020 | 2.41% |
| Sep 30, 2020 | 13.52% |
| Jun 30, 2020 | -31.23% |
| Mar 31, 2020 | 22.24% |
| Sep 30, 2019 | 52.26% |
| Jun 30, 2019 | 38.69% |
| Mar 31, 2019 | 42.89% |
| Mar 31, 2018 | -33.49% |
| Dec 31, 2017 | -29.62% |
| Sep 30, 2017 | 22.82% |
| Jun 30, 2017 | 27.10% |
| Mar 31, 2017 | -34.01% |